TPX-115

N/A

Report date: 2024/05/15 20:00:35

Base Information

Drug NameTPX-115

Drug Alias NameTPX-115TPX-114

ClassificationCell and gene therapy > Cell therapy > Donor > AllogeneicCell and gene therapy > Cell therapy > Somatic cell > Dermal fibroblasts therapy

Mechanisms of ActionCell replacements

TargetsNot applicable

Therapy Area/IndicationsRotator Cuff Injuries

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited StatesSouth Korea

CombinationsNo

Global Highest StatusPhase 3 Clinical

Highest Status in ChinaN/A

Originator CompaniesTego Sciences

China Registration ClassN/A

Develop Information

Active CompaniesTego Science Inc

Inactive CompaniesN/A

Active IndicationsRotator Cuff Injuries

Inactive IndicationsN/A

Other Information

ATC CodeN/A